Annual CFF
$7.50 M
-$53.90 M-87.79%
01 June 2022
Summary:
Pluristem Therapeutics annual cash flow from financing activities is currently $7.50 million, with the most recent change of -$53.90 million (-87.79%) on 01 June 2022. During the last 3 years, it has fallen by -$53.90 million (-87.79%).PSTI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
01 September 2022
Summary:
Pluristem Therapeutics quarterly cash flow from financing activities is not available.PSTI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
01 September 2022
Summary:
Pluristem Therapeutics TTM cash flow from financing activities is not available.PSTI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -87.8% | - | - |
| 5 y5 years | -68.2% | - | - |
PSTI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -87.8% |
Pluristem Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | $7.50 M(-87.8%) | $0.00(-100.0%) | $7.50 M(-76.5%) |
| Mar 2022 | - | $7.50 M(>+9900.0%) | $31.91 M(-46.9%) |
| Dec 2021 | - | $0.00(-100.0%) | $60.12 M(-2.1%) |
| June 2021 | $61.40 M(+0.9%) | $24.41 M(-31.6%) | $61.40 M(-29.0%) |
| Mar 2021 | - | $35.71 M(+3528.9%) | $86.50 M(+54.0%) |
| Dec 2020 | - | $984.00 K(+228.0%) | $56.19 M(-5.1%) |
| Sept 2020 | - | $300.00 K(-99.4%) | $59.19 M(-2.8%) |
| June 2020 | $60.87 M(+158.1%) | $49.51 M(+817.7%) | $60.87 M(+95.6%) |
| Mar 2020 | - | $5.39 M(+35.3%) | $31.12 M(+13.2%) |
| Dec 2019 | - | $3.99 M(+101.2%) | $27.48 M(+10.0%) |
| Sept 2019 | - | $1.98 M(-90.0%) | $24.98 M(+5.9%) |
| June 2019 | $23.58 M(+18.4%) | $19.76 M(+1023.8%) | $23.58 M(+266.6%) |
| Mar 2019 | - | $1.76 M(+18.9%) | $6.43 M(+6.1%) |
| Dec 2018 | - | $1.48 M(+151.5%) | $6.06 M(-68.8%) |
| Sept 2018 | - | $588.00 K(-77.4%) | $19.46 M(-2.3%) |
| June 2018 | $19.92 M(+26.1%) | $2.61 M(+87.7%) | $19.92 M(+14.6%) |
| Mar 2018 | - | $1.39 M(-90.7%) | $17.38 M(-45.2%) |
| Dec 2017 | - | $14.88 M(+1316.7%) | $31.72 M(+88.3%) |
| Sept 2017 | - | $1.05 M(+1421.7%) | $16.84 M(+6.6%) |
| June 2017 | $15.80 M(+1857.5%) | $69.00 K(-99.6%) | $15.80 M(+0.4%) |
| Mar 2017 | - | $15.72 M(>+9900.0%) | $15.73 M(>+9900.0%) |
| Dec 2016 | - | $0.00(-100.0%) | $5000.00(0.0%) |
| Sept 2016 | - | $4000.00(>+9900.0%) | $5000.00(-99.4%) |
| June 2016 | $807.00 K(-95.3%) | $0.00(-100.0%) | $807.00 K(-95.2%) |
| Mar 2016 | - | $1000.00(>+9900.0%) | $16.64 M(-3.4%) |
| Dec 2015 | - | $0.00(-100.0%) | $17.23 M(-3.7%) |
| Sept 2015 | - | $806.00 K(-94.9%) | $17.90 M(+4.1%) |
| June 2015 | $17.20 M(+36.3%) | $15.84 M(+2579.5%) | $17.20 M(+773.6%) |
| Mar 2015 | - | $591.00 K(-11.1%) | $1.97 M(-83.9%) |
| Dec 2014 | - | $665.00 K(+510.1%) | $12.22 M(-0.0%) |
| Sept 2014 | - | $109.00 K(-82.0%) | $12.22 M(-3.2%) |
| June 2014 | $12.62 M(-65.2%) | $604.00 K(-94.4%) | $12.62 M(+2.2%) |
| Mar 2014 | - | $10.84 M(+1518.1%) | $12.36 M(+702.9%) |
| Dec 2013 | - | $670.00 K(+31.6%) | $1.54 M(+16.7%) |
| Sept 2013 | - | $509.00 K(+51.0%) | $1.32 M(-96.4%) |
| June 2013 | $36.30 M(+5644.3%) | $337.00 K(+1365.2%) | $36.30 M(+0.3%) |
| Mar 2013 | - | $23.00 K(-94.9%) | $36.20 M(+0.1%) |
| Dec 2012 | - | $450.00 K(-98.7%) | $36.18 M(+1.0%) |
| Sept 2012 | - | $35.49 M(>+9900.0%) | $35.80 M(+5565.0%) |
| June 2012 | $632.00 K | $235.00 K(-7933.3%) | $632.00 K(-22.0%) |
| Mar 2012 | - | -$3000.00(-103.9%) | $810.00 K(-98.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | $77.00 K(-76.2%) | $42.43 M(-10.0%) |
| Sept 2011 | - | $323.00 K(-21.8%) | $47.13 M(+0.2%) |
| June 2011 | $47.04 M(+690.8%) | $413.00 K(-99.0%) | $47.04 M(-3.9%) |
| Mar 2011 | - | $41.62 M(+770.6%) | $48.97 M(+563.6%) |
| Dec 2010 | - | $4.78 M(+1996.5%) | $7.38 M(+37.1%) |
| Sept 2010 | - | $228.00 K(-90.3%) | $5.38 M(-9.5%) |
| June 2010 | $5.95 M(+9.2%) | $2.34 M(+7703.3%) | $5.95 M(+18.5%) |
| Mar 2010 | - | $30.00 K(-98.9%) | $5.02 M(-16.4%) |
| Dec 2009 | - | $2.78 M(+250.5%) | $6.00 M(+60.8%) |
| Sept 2009 | - | $794.00 K(-43.8%) | $3.73 M(-31.4%) |
| June 2009 | $5.45 M(+183.5%) | $1.41 M(+39.4%) | $5.45 M(+33.7%) |
| Mar 2009 | - | $1.01 M(+97.7%) | $4.07 M(+17.1%) |
| Dec 2008 | - | $513.00 K(-79.5%) | $3.48 M(-14.5%) |
| Sept 2008 | - | $2.51 M(+6167.5%) | $4.07 M(+111.8%) |
| June 2008 | $1.92 M(-77.3%) | $40.00 K(-90.5%) | $1.92 M(-69.1%) |
| Mar 2008 | - | $419.00 K(-62.1%) | $6.22 M(-40.2%) |
| Dec 2007 | - | $1.10 M(+208.7%) | $10.39 M(+18.2%) |
| Sept 2007 | - | $358.00 K(-91.7%) | $8.79 M(+3.6%) |
| June 2007 | $8.48 M(+228.3%) | $4.33 M(-5.6%) | $8.48 M(+26.0%) |
| Mar 2007 | - | $4.59 M(-1034.6%) | $6.73 M(+214.1%) |
| Dec 2006 | - | -$491.00 K(-1062.7%) | $2.14 M(-18.6%) |
| Sept 2006 | - | $51.00 K(-98.0%) | $2.63 M(+2.0%) |
| June 2006 | $2.58 M(-15.5%) | $2.58 M(>+9900.0%) | $2.58 M(+7499.1%) |
| Mar 2006 | - | $0.00(0.0%) | $34.00 K(-98.8%) |
| Dec 2005 | - | $0.00(0.0%) | $2.78 M(-9.0%) |
| Sept 2005 | - | $0.00(-100.0%) | $3.05 M(-0.1%) |
| June 2005 | $3.06 M(+69.9%) | $34.00 K(-98.8%) | $3.06 M(-5.8%) |
| Mar 2005 | - | $2.75 M(+902.4%) | $3.25 M(+84.0%) |
| Dec 2004 | - | $274.00 K(+7958.8%) | $1.76 M(+17.6%) |
| Sept 2004 | - | $3400.00(-98.5%) | $1.50 M(-16.6%) |
| June 2004 | $1.80 M(+90.0%) | $223.60 K(-82.3%) | $1.80 M(-25.8%) |
| Mar 2004 | - | $1.26 M(>+9900.0%) | $2.43 M(+97.2%) |
| Dec 2003 | - | $10.40 K(-96.6%) | $1.23 M(+5.8%) |
| Sept 2003 | - | $302.30 K(-64.5%) | $1.16 M(+22.8%) |
| June 2003 | $947.20 K(+1073.7%) | $851.00 K(+1160.7%) | $947.10 K(+689.9%) |
| Mar 2003 | - | $67.50 K(-217.8%) | $119.90 K(+61.8%) |
| Dec 2002 | - | -$57.30 K(-166.7%) | $74.10 K(-100.4%) |
| Sept 2002 | - | $85.90 K(+260.9%) | -$17.12 M(-0.5%) |
| June 2002 | $80.70 K | $23.80 K(+9.7%) | -$17.20 M(-0.1%) |
| Mar 2002 | - | $21.70 K(-100.1%) | -$17.23 M(-0.1%) |
| Dec 2001 | - | -$17.25 M | -$17.25 M |
FAQ
- What is Pluristem Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Pluristem Therapeutics?
- What is the all time high quarterly CFF for Pluristem Therapeutics?
- What is the all time high TTM CFF for Pluristem Therapeutics?
What is Pluristem Therapeutics annual cash flow from financing activities?
The current annual CFF of PSTI is $7.50 M
What is the all time high annual CFF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual cash flow from financing activities is $61.40 M
What is the all time high quarterly CFF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly cash flow from financing activities is $49.51 M
What is the all time high TTM CFF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM cash flow from financing activities is $86.50 M